SOPHiA GENETICS S.A.

SOPHNASDAQHealthcare● Active

$5.47

+$0.47(+9.32%)

Market Cap$391748281

P/E Ratio—

52W High$5.7

52W Low$2.59

Avg Volume96K

Open$5.18

Beta0.98

Overview

Stock ranking:Medical - Healthcare Information Services·Healthcare·View All Market Cap Rankings →

SOPHiA GENETICS S.A. (SOPH) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · SOPH · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.18Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$81.2MFull revenue history

Dividend YieldNo DividendDividend history

Shares Outstanding67.5MShares outstanding history

Next EarningsAug 4, 2026Est.Earnings history

Explore SOPHiA GENETICS S.A. Data

Market Cap$393.1M

Analyst Forecast$8 · Buy

DividendsNo Dividend

Revenue$77.3M+18.56%

EarningsEPS $-1.17-23.16%

PE Ratio—

Financial Snapshot

Full Financials

FY 2025Revenue$77.3M▲ +18.56% YoY

202320242025

FY 2025Net Income-$79.0M▼ 26.41% YoY

202320242025

FY 2025EPS$-1.17▼ 23.16% YoY

202320242025

TTM:Revenue: $81.2MNet Income: -$80.9MEPS: $-1.18View income statement →

Analyst Ratings & Price Target

Full Forecast

Buy7 analysts

Strong Buy

Buy

Hold

Sell

Strong Sell

12-Month Price Target

$7.00Low

$5.47Current

$7.50Avg Target37.21% upside

$8.00High

Total: 7 · Buy rate: 85.7%

The SOPH analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $7.50, representing +37.21% upside from the current price of $5.47.

Competitors & Peers

#TickerCompanyPriceChangeMkt Cap

SOPH

SOPHiA GENETICS S.A.

$5.47+9.32%$391.7M #2

ACIU

AC Immune S.A.

$2.22-2.00%$225.4M #3

Alto Neuroscience, Inc.

$18.21+0.66%$639.1M #5

CLLS

Cellectis S.A.

$2.96-3.92%$297.2M #6

Definitive Healthcare Corp.

$0.85-4.48%$89.8M

Stock Performance

Full History

1D+9.70%

1W+11.26%

1M+6.50%

3M+26.09%

YTD+17.45%

1Y+91.78%

5Y-67.27%

About SOPHiA GENETICS S.A.

CEOJurgi Camblong

IPO DateJul 23, 2021

Employees423

CountryCH

Websitesophiagenetics.com

SOPHiA GENETICS S.A. SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from mul…

Medical - Healthcare Information Services HealthcareNASDAQCH

About Stock Overview & Key Data

SOPHiA GENETICS S.A. (SOPH) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Jul 23, 2021. As of the latest trading session, SOPH stock price is $5.47, with a market capitalization of $393.1M. The stock has returned +91.78% over the past 12 months and +17.45% year-to-date.

According to 7 Wall Street analysts, the consensus rating for SOPHiA GENETICS S.A. stock is Buy, with an average 12-month price target of $7.50. In fiscal year 2025, SOPHiA GENETICS S.A. reported revenue of $77.3M and net income of -$79.0M. For detailed data — including SOPHiA GENETICS S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, SOPHiA GENETICS S.A. (SOPH) stock price is $5.47. The stock is traded on NASDAQ under the ticker symbol SOPH. The 52-week range is $2.59 – $5.70.

SOPH stock priceSOPH quote todaylive ticker

Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice